Across TCGA pan-cancer cohorts, SLCO1B7 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SLCO1B7 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher SLCO1B7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SLCO1B7 expression acts as an unfavorable survival marker.

SCLC are the cancer types where SLCO1B7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	All	0.055	0.708	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: SLCO1B7 tumor-vs-normal RNA expression · all SLCO1B7 data types